A study showed that if the booster is the same as the first two doses, it boosts immunity well, but when the booster dose is different, the...

The move, by the health ministry, came a day before precautionary doses are to be made available to everyone over the age of 18.

The government on Saturday announced that precaution dose of COVID-19 vaccines will be available to all aged above 18 years at private vacc...

In heterologous doses' trials, a participant receives Covaxin followed by Covishield and vice versa. The Drug Controller General of India h...

Pune-based SII's Covishield and Bharat Biotech's Covaxin were granted conditional market authorisation by India's drug regulator on Thursda...

The Indian Council of Medical Research's NIE has proposed to conduct phase-2 safety and immunogenicity study specifically on people with co...

The study titled-Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, doub...

The third dose of the Covid vaccine to be given to healthcare workers, frontline workers and those aged 60 years and above with comorbiditi...

Zydus Cadila's vaccine ZyCoV-D has not yet been introduced in the country's inoculation programme, even for adults, though it had received ...

"The trials are ongoing, and we expect to submit data by the end of this year," a company insider said. The trials, including over 600 part...

The Centre has spent Rs 8,071.09 crore to buy vaccines and remaining about `1,654.06 crore on operational costs for administering the vacci...

Company's co-founder and joint managing director Suchitra Ella on Wednesday tweeted that Andhra Pradesh, Assam, Delhi, Gujarat, Karnataka, ...

Justice Rekha Palli expressed happiness over the development and the proactive steps taken by both the Central and Delhi government to addr...

The mismatch between reported production numbers of Covid vaccines in India and the level of daily vaccination seems particularly acute in ...

The government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.

Speaking to ET, Punjab health minister Balbir Singh Sidhu said: “We don’t want to deploy the vaccine right away. Our expert panel of doctor...

"I will be administered a trial dose of Coronavirus vaccine #Covaxin a Bharat Biotech product Tomorrow at 11 am at Civil hospital, Ambala C...